Cibus, Inc. Form 8-K Summary
Business Context and Reporting Period
Cibus, Inc. (CBUS), a Delaware corporation, filed this Current Report on Form 8-K on March 25, 2026. The filing discloses the entry into an underwriting agreement for a public offering of Class A common stock. The company is headquartered in San Diego, California.
Key Financial Metrics and Offering Details
- Offering Size: 6,976,744 shares of Class A Common Stock.
- Offering Price: $2.15 per share.
- Over-Allotment Option: Underwriter granted a 30-day option to purchase up to 1,046,511 additional shares.
- Estimated Net Proceeds: Approximately $13.5 million (base case) or $16.0 million (if over-allotment is fully exercised), after deducting underwriting compensation and offering expenses.
- Underwriting Discount: 7.0% of gross proceeds.
- Expense Reimbursement: Up to $150,000 for underwriter legal and out-of-pocket expenses.
- Closing Date: Expected on or about March 27, 2026.
Note: This filing does not provide historical revenue, profit, cash flow, margin, debt, or liquidity metrics. Those figures are referenced as being available in the Company's Annual Report on Form 10-K filed on March 17, 2026.
Material Changes and Agreements
The primary material event is the capital raise via the underwritten public offering. Key contractual terms include:
- Lock-Up Agreement: The Company, its directors, and executive officers agreed not to sell or transfer Class A Common Stock for 60 days following the Underwriting Agreement date, subject to exceptions.
- Indemnification: The Company agreed to indemnify the underwriter against certain liabilities under the Securities Act of 1933.
Guidance, Outlook, and Risks
The filing contains forward-looking statements regarding the anticipated closing of the offering and expected proceeds. Management highlights the following risks and contingencies:
- Closing Conditions: The offering is subject to customary closing conditions, and there is no guarantee the offering will close on a timely basis or at all.
- Market Risks: General risks detailed in the Company's Form 10-K and the Prospectus Supplement filed on March 26, 2026.
Investor Verification Checklist
- Verify the final closing date and actual net proceeds received after the March 27, 2026 expected closing.
- Confirm whether the underwriter exercises the 30-day over-allotment option for an additional 1,046,511 shares.
- Review the Prospectus Supplement filed on March 26, 2026, for detailed use of proceeds and risk factors.
- Consult the Form 10-K filed on March 17, 2026, for the company's most recent audited financial position, liquidity, and debt levels.
- Monitor compliance with the 60-day lock-up period for insiders and the company.